Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib
Grigorios Theodosiou, Åke Svensson · 2026
Read Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib by Grigorios Theodosiou, Åke Svensson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13617169.txt.
Description
Grigorios Theodosiou and Åke Svensson report a paradoxical skin reaction in a teenager treated for severe eczema. Eight months into dupilumab therapy, he developed widespread psoriasis-like dermatitis. This effect of the drug is known but uncommon, and reports in children and teens remain limited.
The clinicians switched his treatment to abrocitinib, a daily pill. The psoriasis-like lesions nearly cleared fully. The eczema underneath stayed well controlled at the same time. The authors present the switch as a sound alternative that handles both conditions at once. The case adds evidence from a young patient to a small literature. It offers a practical route for care when dupilumab triggers psoriasis.
Catalog record
| CREATOR | Grigorios Theodosiou, Åke Svensson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |